Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Saturday, February 11, 2017

AMSBIO publishes new catalogue that details cutting edge tools for neuroscience research

Just in case you need to supply information to your doctor for research. Ask your doctor about how some of the big words will finally get every stroke patient 100% recovered. S/he should be up-to-date on current research. If not, YOU will need to do your doctors work for them and yourself unless you are rich enough to hire your own researchers. Because our fucking failures of stroke associations will be doing nothing and we have NO stroke leadership or strategy to solve all the fucking problems in stroke.
cryopreservation media
neural transfection
isogenic models
extracellular matrices
iPSC-derived cells
ELISA kits
http://www.news-medical.net/news/20170209/AMSBIO-publishes-new-catalogue-that-details-cutting-edge-tools-for-neuroscience-research.aspx
AMSBIO has published a new 25-page Neuroscience catalogue that details its extensive range of specific tools and reagents to enable researchers stay at the forefront of their field.

Cellular models are key tools that open the door to numerous neuroscience applications including neurodegeneration, neurogensis and developmental diseases. With the discovery that neural stem cells exist in the adult brain many researchers are now seeking to use these cells in in vitro studies. To restore normal function in numerous disorders, including Parkinson's Disease and Alzheimers Disease, neural stem cell transplantation is an important emerging strategy. Furthermore, the recent advent of iPSC and genome editing technology including CRISPR has transformed the scope of neuroscience research allowing the generation of isogenic models and the ability to obtain large numbers of neural stem cells, which had been traditionally difficult to obtain. As many researchers acknowledge the importance of studying the behaviour of neurons, glial cells and neural stem cells with a physiologically relevant context the importance of 3D cell culture has grown.
Beautifully illustrated the new catalogue provides detailed information on the latest neural stem cells, cell culture media / supplements, matrices, scaffolds, cryopreservation media and neural transfection products available from AMSBIO.
AMSBIO is a leading transatlantic based source for neural cells, media and supplements including iPSC-derived cells. The company's large range of substrates and matrices including natural extracellular matrices and artificial scaffolds give you numerous options to develop your in vitro system. AMSBIO also offer proteins, specialised antibodies, ELISA kits, cryopreservation media and an extensive biorepository with neural tissue from numerous species. AMSBIO has an active program of cooperation with leading labs around the world enabling it to continually add new resources to its cutting edge neuroscience range.

No comments:

Post a Comment